Yusheng Guo
Overview
Explore the profile of Yusheng Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Y, Pan Z, Kan X, Li T, Gong B, Li Y, et al.
Int Immunopharmacol
. 2025 Jan;
147():114006.
PMID: 39793227
Background: Although several studies have compared the efficacy and safety of transarterial chemoembolization (TACE) without immune checkpoint inhibitors (ICIs) and TACE with ICIs, there is still a lack of meta-analysis....
2.
Lou J, Guo Y, Li L, Yang Y, Liu C, Zheng C, et al.
Int Immunopharmacol
. 2024 Nov;
144:113699.
PMID: 39615113
Background: Although recent studies have reported that obesity is a protective factor for survival in patients with advanced cancers treated with immune checkpoint inhibitors (ICIs), the prognostic value of CT-derived...
3.
Guo Y, Li T, Gong B, Hu Y, Wang S, Yang L, et al.
Adv Sci (Weinh)
. 2024 Nov;
12(2):e2408069.
PMID: 39535476
With the increasing demand for precision medicine in cancer patients, radiogenomics emerges as a promising frontier. Radiogenomics is originally defined as a methodology for associating gene expression information from high-throughput...
4.
Guo Y, Li T, Xie J, Luo M, Zheng C
J Hepatol
. 2024 Sep;
82(1):e15-e17.
PMID: 39307371
No abstract available.
5.
Bai Y, Liu J, Wu W, Zhou B, Sun B, Yao W, et al.
Eur J Radiol
. 2024 Sep;
181:111740.
PMID: 39288645
Objective: The consensus on whether Transjugular intrahepatic portosystemic shunt (TIPS) should be combined with variceal embolization in the treatment of portal hypertension-induced bleeding has not yet been reached. This study...
6.
Ren Y, Zhu L, Guo Y, Ma J, Yang L, Zheng C, et al.
J Pharm Anal
. 2024 Sep;
14(8):100942.
PMID: 39263355
The hypoxic microenvironment and inflammatory state of residual tumors caused by insufficient radiofrequency ablation (iRFA) are major reasons for rapid tumor progression and pose challenges for immunotherapy. We retrospectively analyzed...
7.
Jiang S, Li Y, Guo Y, Gong B, Wei C, Liu W, et al.
Sci Rep
. 2024 Sep;
14(1):20896.
PMID: 39245685
The purpose of this study is to evaluate whether the periprostatic adipose tissue thickness (PPATT) is an independent prognostic factor for prostate cancer patients after laparoscopic radical prostatectomy (LRP). This...
8.
Cai X, Yang J, Guo Y, Yu Y, Zheng C, Dai X
J Transl Med
. 2024 Aug;
22(1):807.
PMID: 39215354
Background: At present, immunotherapy has become a powerful treatment for advanced gastric cancer (AGC), but not all patients can benefit from it. According to the latest research, the impact of...
9.
Tian W, Jia Q, Lin J, Luo J, He D, Yang J, et al.
Sci Adv
. 2024 Aug;
10(32):eadn0367.
PMID: 39121219
The development of noninvasive approaches to precisely control neural activity in mammals is highly desirable. Here, we used the ion channel transient receptor potential ankyrin-repeat 1 (TRPA1) as a proof...
10.
Li Y, Gong B, Lou J, Guo Y, Liang B, Liu W, et al.
Transl Lung Cancer Res
. 2024 Aug;
13(7):1544-1558.
PMID: 39118894
Background: Although the thymus undergoes degeneration with the advancement of age, recent studies have continuously revealed that the thymus possesses the potential for regeneration and may reverse this aging trend....